A gel that may save the tooth next door: wisdom tooth extraction gets a preventive upgrade
NCT ID NCT07718932
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This trial tests whether applying a regenerative gel called Emdogain to the root of the second molar during wisdom tooth removal can prevent the deep pockets and bone loss that often develop on that tooth afterward. The study involves 70 healthy adults who need a lower wisdom tooth removed. Half will receive the gel during surgery; the other half will heal naturally. Researchers will measure changes in gum attachment and bone levels over six months to see if the gel leads to better healing.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a regenerative gel made from enamel matrix proteins (Emdogain)
- What this could lead to
- If it works, this could offer a simple, one-time preventive step during wisdom tooth extraction to protect the adjacent molar from gum disease and bone loss.
- What could go wrong
- This is a small, early-stage trial with 70 participants. The gel may not improve healing over natural recovery, and its effects beyond 6 months are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy adult patients aged 18 to 35 years old (ASA I or II). * Presence of an asymptomatic, partially or fully impacted mandibular third molar requiring surgical extraction. * The third molar impaction must be mesioangular or horizontal, with its crown in direct physical contact with the adjacent second molar, as assessed by a preoperative panoramic radiograph. * The adjacent mandibular second molar must be vital, fully erupted, and structurally sound (free of extensive dental caries or prosthetic crowns). * Patients must demonstrate an adequate level of overall oral hygiene and gingival health (e.g., Full-Mouth Plaque Index \< 20% and Full-Mouth Bleeding Score \< 20% following initial prophylaxis and oral hygiene instructions). * Willingness to comply with postoperative instructions and adhere to the scheduled follow-up visits. * Ability to understand the study procedures and voluntarily sign the informed consent form. Exclusion Criteria * Presence of systemic diseases or conditions that could compromise wound healing or periodontal health (e.g., uncontrolled diabetes mellitus, autoimmune disorders). * Current or recent use of medications known to affect bone metabolism or wound healing (e.g., bisphosphonates, long-term systemic corticosteroids, immunosuppressants). * History of heavy smoking (e.g., \>10 cigarettes per day) or use of smokeless tobacco products. * Pregnant or lactating females. * Diagnosis of periodontitis (Stage II, III, or IV) affecting the remaining dentition, excluding the localized defect associated with the impacted third molar. * Presence of active acute infection (e.g., purulent pericoronitis) or radiolucent pathologic lesions extending beyond the normal follicular space (e.g., dentigerous cysts) that would significantly alter the baseline bony defect morphology. * Known allergy or hypersensitivity to any of the medications utilized in the surgical or postoperative protocol (e.g., local anesthetics, prescribed antibiotics, or analgesics). * Previous orthodontic treatment utilizing bands on the mandibular second molars that could have affected the periodontal attachment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alveolar bone loss are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
424 General Military Hospital
RECRUITINGThessaloniki, Greece
-
Aristotle University of Thessaloniki
RECRUITINGThessaloniki, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a custom healing cap preserve gum and bone after tooth extraction?
- Your extracted tooth may become the next bone graft
- Can a new surgical trick save the bone that holds your dental implant?
- Can a smart gel regrow jawbone after tooth extraction?
- Can AI and Tooth-Derived grafts make dental implants more precise?
- Can a 3D-Printed tooth preserve your gum line after extraction?